Usana Health Sciences Raises FY20 EPS Guidance From $4.70-$5.25 To $5.15-$5.45 vs $5.18 Est.; Raises Sales Guidance From $1.050B-$1.100B To $1.090B-$1.115B vs $1.08B Est.